| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/16/2007 | WO2007092000A1 Inhibitors of hcv replication |
| 08/16/2007 | WO2007091948A2 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091947A2 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091946A1 Use of spiro [ imidazolidine-4, 3'-indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091350A1 Solid-phase membrane containing surface-modified albumin or surface-modified serum albumin-metal porphyrin complex and use thereof |
| 08/16/2007 | WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators |
| 08/16/2007 | WO2007061882A3 Pyrrolotriazine kinase inhibitors |
| 08/16/2007 | US20070191455 Substituted sym-triindole |
| 08/16/2007 | US20070191447 Novel heterocyclic compound |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191406 Heterocyclic antiviral compounds |
| 08/16/2007 | US20070191402 Method of searching substrate having antidiabetic activity |
| 08/16/2007 | US20070191399 Zaleplon synthesis |
| 08/16/2007 | US20070191395 Heterocyclic compounds having antifungal activity |
| 08/16/2007 | US20070191394 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia |
| 08/16/2007 | US20070191393 Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191384 9-(2-Oxo-2-phenyl-ethyl)-2-(4-pyridinyl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta and tau protein kinase inhibitor; neurodegenerative diseases: Alzheimer's disease, vascular dementia; acute stroke, retinopathy, glaucoma, alopecia |
| 08/16/2007 | US20070191381 Novel pharmaceutical compounds |
| 08/16/2007 | US20070191376 Bicyclic heteroaryl compounds |
| 08/16/2007 | US20070191375 CRYSTALLINE FORMS OF (3R,4R)-4-AMINO-1-[[4-[(3-METHOXYPHENYL)AMINO]PYRROLO[2,1-f][1,2,4]TRIAZIN-5-YL]METHYL]PIPERIDIN-3-OL |
| 08/16/2007 | US20070191374 Substituted cinnolin-4-ylamines |
| 08/16/2007 | US20070191349 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4] benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases |
| 08/16/2007 | US20070191337 Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same |
| 08/16/2007 | US20070191335 Heterocylic antiviral compounds |
| 08/16/2007 | US20070191329 Ethylene glycol esters as photoactive agents |
| 08/16/2007 | US20070191312 Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as beta-lactamase inhibitors and antibacterials |
| 08/16/2007 | US20070191309 a 7 or 8-hydroxy; a protected oxygen at position 11; carbamate protecting group at the N10 position (oxycarbonyl); reaction with a diiodoalkane; antitumour anthramycin antibiotic |
| 08/16/2007 | US20070191293 Inhibitors of E1 activating enzymes |
| 08/16/2007 | US20070191260 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug containing the derivative |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190041 Novel benzothiazepine and bensothiepine compounds |
| 08/16/2007 | US20070188078 Triazole derivatives and use thereof in organic light-emitting diodes (oleds) |
| 08/16/2007 | CA2642154A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
| 08/16/2007 | CA2641632A1 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/15/2007 | EP1658292B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/15/2007 | EP1554280B1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
| 08/15/2007 | EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | CN1331866C Method for continuous extracting chlorophyll from silkworm dropping |
| 08/15/2007 | CN1331865C Polymorphs and compositions and methods related thereto |
| 08/15/2007 | CN1331864C Novel 2,5-diazabicyclo [2.2.1] heptane derivatives |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018787A Ligands for G-protein coupled receptors |
| 08/15/2007 | CN101018768A Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 08/15/2007 | CN101016303A Protective agent for a plurality of stabilization porphyrin substance bioactivity and using method thereof |
| 08/15/2007 | CN101016302A Method of reclaiming methenamine and glycine from glycine dealcoholization mother liquid |
| 08/15/2007 | CN101016301A Triazole miazines derivative |
| 08/15/2007 | CN101016300A Triazole pyrimidine sulphonates compound, preparing method and application thereof |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/14/2007 | US7256311 Process for hydrogenating unactivated imines using ruthenium complexes as catalysts |
| 08/14/2007 | US7256289 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol |
| 08/14/2007 | US7256198 Pyrimidoindolones and methods for using same |
| 08/14/2007 | US7256190 Thiazole compounds useful as inhibitors of protein kinase |
| 08/14/2007 | US7255779 Indolecarboxylic ester trimer and electrochemical cell using the same |
| 08/14/2007 | US7255733 Dry-milling a crude copper phthalocyanine to prepare an alpha / beta mixed crystal type copper phthalocyanine and treating with an organic solvent; another phthalocyanine compound is added before, during or after milling; printing inks, coating compositions and colored molding plastics |
| 08/09/2007 | WO2007089512A1 Glucokinase activators |
| 08/09/2007 | WO2007089018A1 Triazole derivative |
| 08/09/2007 | WO2007088277A1 Tricyclic ν-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 08/09/2007 | WO2007088168A1 Compounds |
| 08/09/2007 | WO2007088148A1 Derivatives of thiophene carboxilic acid as antiviral agent |
| 08/09/2007 | WO2007088073A1 Zopiclone resolution using l-tartaric acid |
| 08/09/2007 | WO2007071965A3 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines |
| 08/09/2007 | WO2007059404A3 Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| 08/09/2007 | WO2007053343A3 Compounds and compositions as protein kinase inhibitors |
| 08/09/2007 | US20070185327 Preparation of substituted quinoxalines |
| 08/09/2007 | US20070185325 2,4-dioxopyrimidine-based mesoionic pigments |
| 08/09/2007 | US20070185179 New compounds |
| 08/09/2007 | US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 08/09/2007 | US20070185148 M3 muscarinic acetylchoine receptor antagonists |
| 08/09/2007 | US20070185143 Anticarcinogenic agents, antimetastasis agents; angiogenesis inhibitors; transplant rejection |
| 08/09/2007 | US20070185138 Imidazolopyrimidines used as fungicidal active ingredients |
| 08/09/2007 | US20070185137 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders |
| 08/09/2007 | US20070185121 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents |
| 08/09/2007 | US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/09/2007 | US20070185106 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
| 08/09/2007 | US20070185103 Beta-Secretase inhibitors such as 1-cyclopentyl-N-((2S,3R)-4-((S)-6-ethyl-2,2-spirocyclobutylchroman-4-ylamino)-3-hydroxy-1-(thiophen-3-yl)butan-2-yl)-6-oxo-5-(2-oxopyrrolidin-1-yl)-1,6-dihydropyridine-3-carboxamide, useful for the treatment of Alzheimer's disease |
| 08/09/2007 | US20070185099 Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
| 08/09/2007 | US20070185097 7-(4-Chlorophenyl)-2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one trifluoroacetic acid salt; obesity; antidiabetic agents; antidepressants; anxiolytic agents; combination with antipsychotic drugs enhanced therayp for schizophrenic disorders |
| 08/09/2007 | US20070185095 Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 08/09/2007 | US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders |
| 08/09/2007 | US20070185087 Compounds and methods for inhibiting mitotic progression |
| 08/09/2007 | US20070185086 Pharmaceutical Compositions and Methods for Effecting Dopamine Release |
| 08/09/2007 | US20070185083 HCV NS5B Inhibitors |
| 08/09/2007 | US20070185078 e.g. 8-Methoxy-1-(2'-methoxybiphenyl-4-yl)-4H,6H-[1,2,4]triazolo[4,3-a][4,1 ]benzoxazepine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure |
| 08/09/2007 | US20070185064 2-Aminopurine Analogs Having HSP90-Inhibiting Activity |
| 08/09/2007 | US20070185007 Inhibition of HiV integrase compounds |
| 08/09/2007 | US20070184024 RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease; (+/-)-8-Cyclohexyl-N-4-(morpholinosulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide |
| 08/09/2007 | US20070181416 Process and apparatus for preparing metal or nonmetal phthalocyanine |
| 08/09/2007 | CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 08/09/2007 | CA2637333A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 08/09/2007 | CA2637172A1 Pyridin-2-amine derivatives and their use as glucokinase activators |
| 08/08/2007 | EP1814885A2 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 08/08/2007 | EP1814884A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 08/08/2007 | EP1814883A1 Bicyclic inhibitors or rho kinase |
| 08/08/2007 | EP1814882A1 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |